GLYCEROPHOSPHOLIPIDS FOR THE IMPROVEMENT OF COGNITIVE FUNCTIONS

摘要

The present document relates to a method of improving a condition in a subject suffering from a cognitive disease or disorder which comprises administering to the subject an effective amount of a preparation comprising a non-mammalian derived mixture of serine glycerophospholipid conjugates, where the mixture comprises (a) linoleic acid (c18:2) conjugated to phosphatidylserine (PS), (b) docosahexaenoic acid (DHA) conjugated to PS, and (f) eicosapentaenoic acid (EPA) conjugated to PS, in which mixture the w/w% of (a) / the w/w% of (b) is from about 0.09 to about 3.6 and the w/w% of (a) / w/w% of (f) is from about 0.23 to about 9.4.